Concepedia

Publication | Open Access

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial

DOIFull Paper Access

94

Citations

19

References

2018

Year

Stephen C. Bain, Ofri Mosenzon, Rosario Arechavaleta, Paweł Bogdański, Abdurrahman Çömlekçi, Agostino Consoli, Chaicharn Deerochanawong, Kathleen Dungan, María Cristina Faingold, Michael E. Farkouh,
Diabetes Obesity and Metabolism

Abstract

PIONEER 6 will provide evidence regarding the CV safety of oral semaglutide in patients with type 2 diabetes and high CV risk.

References

YearCitations

Page 1